INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "TREATMENT OF SYSTEMIC SCLEROSIS USING A POPULATION OF CD19 CAR-EXPRESSING CELLS"

GENEVA, May 4 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/060754) for "TREATMENT OF SYSTEMIC SCLEROSIS USING A POPULATION OF CD19 CAR-EXPRESSING CELLS" on Oct 22, 2025. With publication no. WO/2026/088096, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ADIWIJAYA, Bambang Senoaji (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), PEARSON, David Scott (Novartis Pharma AGLichtstrasse 354056 Basel), STORIM, Julian (Novartis Pharma AGLichtstrasse 354056 Basel...